Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wilma Barcellini, Juri Giannotta & Bruno Fattizzo. (2020) Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Review of Hematology 13:6, pages 585-597.
Read now
Read now
Articles from other publishers (22)
George N Goulielmos & Maria I Zervou. (2023) Correspondence on ‘Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia: a nationwide population-based cohort study’. Annals of the Rheumatic Diseases 82:1, pages e19-e19.
Crossref
Crossref
M. M. Khalifa, N. E. Zaki, A. A. Nazier, M. A. Moussa, R. Abdel Haleem, M. A. Rabie & A. R. Mansour. (2021) Prognostic significance of microRNA 17–92 cluster expression in Egyptian chronic lymphocytic leukemia patients. Journal of the Egyptian National Cancer Institute 33:1.
Crossref
Crossref
Chihiro Ochiai, Sonoko Miyauchi, Yuta Kudo, Yuta Naruke, Syuji Yoneyama, Keisuke Tomita, Leng Dongze, Yusuke Chiba, To-ichi Hirata, Toshihiro Ichijo, Kazuya Nagai, Sota Kobayashi, Shinji Yamada, Hirokazu Hikono & Kenji Murakami. (2021) Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing. PLOS ONE 16:9, pages e0256588.
Crossref
Crossref
Nil Albiol & Carol Moreno. (2021) Autoimmune Cytopenia in CLL. The Cancer Journal 27:4, pages 286-296.
Crossref
Crossref
Sylwia Sulimiera Michalak, Anna Olewicz-Gawlik, Joanna Rupa-Matysek, Edyta Wolny-Rokicka, Elżbieta Nowakowska & Lidia Gil. (2020) Autoimmune hemolytic anemia: current knowledge and perspectives. Immunity & Ageing 17:1.
Crossref
Crossref
Delphine Casabonne, Yolanda Benavente, Julia Seifert, Laura Costas, María Armesto, María Arestin, Caroline Besson, Fatemeh S. Hosnijeh, Eric J. Duell, Elisabete Weiderpass, Giovanna Masala, Rudolf Kaaks, Federico Canzian, María‐Dolores Chirlaque, Vittorio Perduca, Francesca R. Mancini, Valeria Pala, Antonia Trichopoulou, Anna Karakatsani, Carlo La Vecchia, Maria‐Jose Sánchez, Rosario Tumino, Marc J. Gunter, Pilar Amiano, Salvatore Panico, Carlotta Sacerdote, Julie A. Schmidt, Heiner Boeing, Matthias B. Schulze, Aurelio Barricarte, Elio Riboli, Anja Olsen, Anne Tjønneland, Roel Vermeulen, Alexandra Nieters, Charles H. Lawrie & Silvia Sanjosé. (2020)
Serum levels of
hsa‐miR‐16‐5p
,
hsa‐miR‐29a‐3p
,
hsa‐miR‐150‐5p
,
hsa‐miR‐155‐5p
and
hsa‐miR
‐
223‐3p
and subsequent risk of chronic lymphocytic leukemia in the EPIC study
. International Journal of Cancer 147:5, pages 1315-1324.
Crossref
Crossref
Bruno Fattizzo & Wilma Barcellini. (2020) Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects. Frontiers in Oncology 9.
Crossref
Crossref
Carol Moreno, Carolina Cuellar & Eva Puy Vicente. 2019. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
123
136
.
Mirco Marco, Alice Ramassone, Sara Pagotto, Eleni Anastasiadou, Angelo Veronese & Rosa Visone. (2018) MicroRNAs in Autoimmunity and Hematological Malignancies. International Journal of Molecular Sciences 19:10, pages 3139.
Crossref
Crossref
Qin Yang, Wenjie Cao, Zi Wang, Bin Zhang & Jing Liu. (2018) Regulation of cancer immune escape: The roles of miRNAs in immune checkpoint proteins. Cancer Letters 431, pages 73-84.
Crossref
Crossref
Limin Xing, Wenyan Xu, Yingying Qu, Manjun Zhao, Hongli Zhu, Hong Liu, Huaquan Wang, Xin Su & Zonghong Shao. (2018) miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb. International Journal of Hematology 107:6, pages 666-672.
Crossref
Crossref
J. Lin, J.-C. Ma, J. Yang, J.-Y. Yin, X.-X. Chen, H. Guo, X.-M. Wen, T.-J. Zhang, W. Qian, J. Qian & Z.-Q. Deng. (2018) Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression. Oncogene 37:18, pages 2432-2443.
Crossref
Crossref
Ece Eksin, Santosh Kumar Bikkarolla, Arzum Erdem & Pagona Papakonstantinou. (2018) Chitosan/Nitrogen Doped Reduced Graphene Oxide Modified Biosensor for Impedimetric Detection of microRNA. Electroanalysis 30:3, pages 551-560.
Crossref
Crossref
Tao He, Peijie Chen, Lu Jin, Jia Hu, Yifan Li, Liang Zhou, Shangqi Yang, Xiangming Mao, Yaoting Gui, Yun Chen & Yongqing Lai. (2017) miR‑660‑5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma. Molecular Medicine Reports.
Crossref
Crossref
Binglin Yue, Jiyao Wu, Yanhuan Wang, Chunlei Zhang, Xingtang Fang & Hong Chen. (2017) Expression Profiles Analysis and Functional Characterization of MicroRNA-660 in Skeletal Muscle Differentiation. Journal of Cellular Biochemistry 118:8, pages 2387-2394.
Crossref
Crossref
A Navarro, S Pairet, A Álvarez-Larrán, A Pons, G Ferrer, R Longarón, C Fernández-Rodríguez, L Camacho, M Monzó, C Besses & B Bellosillo. (2016) miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia. Blood Cancer Journal 6:3, pages e406-e406.
Crossref
Crossref
E Vasyutina, J M Boucas, J Bloehdorn, C Aszyk, G Crispatzu, M Stiefelhagen, A Breuer, P Mayer, C Lengerke, H Döhner, D Beutner, A Rosenwald, S Stilgenbauer, M Hallek, A Benner & M Herling. (2015) The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL. Leukemia 29:10, pages 2003-2014.
Crossref
Crossref
V C Gourzi, E K Kapsogeorgou, N C Kyriakidis & A G Tzioufas. (2015) Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome. Clinical and Experimental Immunology 182:1, pages 14-22.
Crossref
Crossref
O Fortunato, M Boeri, M Moro, C Verri, M Mensah, D Conte, L Caleca, L Roz, U Pastorino & G Sozzi. (2014) Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction. Cell Death & Disease 5:12, pages e1564-e1564.
Crossref
Crossref
Guanghui Cui, Mingwei Cui, Yuhang Li, Youguang Liang, Weihao Li, Haizhou Guo & Song Zhao. (2014) MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells. Tumor Biology 35:9, pages 8933-8937.
Crossref
Crossref
M Zhang, Z Luo, H Liu, C M Croce, T R BurkeJrJr & D P Bottaro. (2013) Synergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist. Leukemia 28:4, pages 948-951.
Crossref
Crossref
Guining Li, Fenghua Chen, Shenzong Rao & Lihua Hu. (2014) Faulty blood typing misled by auto anti-D in AIHA. Transfusion and Apheresis Science 50:2, pages 269-270.
Crossref
Crossref